Darlene McCord
Dr. Darlene McCord is one of the two founders of McCord Research. Dr. Darlene McCord is widely published on subjects related to immunodermatology and corneotherapy. Dr. Darlene McCord is known for her work, as a biochemist, in skin and wound care.
| Headline: | Scientist |
| Work status: | Employed Full-Time |
| Website: | http://www.darlene-mccord.com |
| Industries: | Biotech, Health |
| Location: | Iowa City |
| Interested in: | Consulting opportunities, Learning about entrepreneurship, Meeting new people, Offering Expertise, Patenting my idea, Professional opportunities |
| Tags: | corneotherapy, darlene mccord, dr darlene mccord ph.d., mccord research, olivamine, remedy, skin care, skin disorters, wound care |
FULL BIO
Dr. Darlene McCord is one of the two founders of McCord Research. As senior researcher, she brings a unique blend of scientific credentials to the position. Through her leadership, the company has achieved worldwide recognition in the OTC Drug and Medical Device categories. Her field of specialty is corneotherapy, focusing on the transport of small molecules across the stratum corneum for treatment of skin disorders associated with distressed and wounded skin. Dr. Darlene McCord is widely published on subjects related to immunodermatology and corneotherapy.
Dr. Darlene McCord is known for her work, as a biochemist, in skin and wound care. She has been awarded two patents and six medical devices in the field. She currently has more than 30 skin health products being sold around the world. Dr. Darlene McCord’s most current commercialized skin and wound care product offering is the Remedy brand distributed by Medline Industries. The line is based on a proprietary blend of small molecules called OlivamineTM that provide corneotherapeutic support for diseased skin. Previously, Dr. Darlene McCord developed the Restore line for Hollister and the Cavalon line for 3M. She is currently working with the University of Iowa on compounds that may reverse early stages of necrosis and that can activate GO quiescent cells in the chronic wound environment.
Dr. Darlene McCord received her first patent in 1993. The patent and the products developed were immediately licensed to one of the country’s premier wound care companies. Her second patent was awarded in 1997. This patent was licensed immediately and the products have become some of the most important in the wound care industry. The second patent is based upon a fetal in-utero wound healing model and its implications for adult wound healing. Dr. Darlene McCord continues to pursue her interests in skin repair systems, barrier repair systems, cancer, and diabetes.
Dr. Darlene McCord’s work has led to global recognition in the field of skin and wound repair. Her mission remains improving the quality of life for people in every country of the world.
PUBLICATIONS
| Articles: | COMMONLY USED BABY SKIN CARE PRODUCTS CONTAIN CHEMICALS THAT PUT INFANTS AT SUBSTANTIAL RISK - Darlene McCord, Ph.D. McCord Research
Cell Death and Proliferation by Darlene McCord, Ph.D., FAPWCA Implications of Corneotherapy and Reduction of Excessive Transepidermal Water Loss by Darlene McCord, Ph.D. Nutrients for Skin Health by Darlene McCord Skin Disease and Treatment with Olivamine by Darlene McCord, Ph.D. FAPWCA Selecting Skin Care Products for Use in Hyperbaric Chamber May be Dependent upon Flammability Acceptability Indices Score by Darlene E. McCord, Ph.D. FAPWCA Neonatal Emollient Flammability by Darlene McCord, Ph. D. Neonate Skin Products Used in Oxygen-Enriched Environments May Pose Risks Associated with Flammability and Skin Breakdown by Darlene McCord, Ph.D., FAPWCA, Barry E. Newton, BSME, PE, Gwenael Chiffoleau, Ph.D Topical Micronutrient Products Significantly Reduced Radiation Dermatitis And Improved Patient Quality of Life Scores in a Year-Over-Year Study Of Eighty Two Patients by Darlene McCord, Ph.D., FAPWCA, David E. Davenport, M.D., FACR, Brenda Bull R.T. (R)(T) Matching Emollient Neonatal Skin Care Product Selection With Changes in the Standard of Care: A Three Decade Evolution by Darlene McCord, Ph.D SKIN CLEANSING by Darlene McCord, Ph.D., FAPWCA DIABETIC SKIN CARE by Nelson J. Gurll, M.D., F.A.P.W.C.A., and Darlene E. McCord, Ph.D., F.A.P.W.C.A.- McCord Research, Inc. |
| Papers: | COMMONLY USED BABY SKIN CARE PRODUCTS CONTAIN CHEMICALS THAT PUT INFANTS AT SUBSTANTIAL RISK - Darlene McCord, Ph.D. McCord Research
Cell Death and Proliferation by Darlene McCord, Ph.D., FAPWCA Implications of Corneotherapy and Reduction of Excessive Transepidermal Water Loss by Darlene McCord, Ph.D. Nutrients for Skin Health by Darlene McCord Skin Disease and Treatment with Olivamine by Darlene McCord, Ph.D. FAPWCA Selecting Skin Care Products for Use in Hyperbaric Chamber May be Dependent upon Flammability Acceptability Indices Score by Darlene E. McCord, Ph.D. FAPWCA Neonatal Emollient Flammability by Darlene McCord, Ph. D. Neonate Skin Products Used in Oxygen-Enriched Environments May Pose Risks Associated with Flammability and Skin Breakdown by Darlene McCord, Ph.D., FAPWCA, Barry E. Newton, BSME, PE, Gwenael Chiffoleau, Ph.D Topical Micronutrient Products Significantly Reduced Radiation Dermatitis And Improved Patient Quality of Life Scores in a Year-Over-Year Study Of Eighty Two Patients by Darlene McCord, Ph.D., FAPWCA, David E. Davenport, M.D., FACR, Brenda Bull R.T. (R)(T) Matching Emollient Neonatal Skin Care Product Selection With Changes in the Standard of Care: A Three Decade Evolution by Darlene McCord, Ph.D SKIN CLEANSING by Darlene McCord, Ph.D., FAPWCA DIABETIC SKIN CARE by Nelson J. Gurll, M.D., F.A.P.W.C.A., and Darlene E. McCord, Ph.D., F.A.P.W.C.A.- McCord Research, Inc. |
